抗血栓治疗的时间模式和心房相关中风后的临床结果
Keon-Joo Lee1, Hoonji Oh2, Han-Gil Jeong3
1Department of Neurology Korea University Guro Hospital Seoul Korea.
Journal of the American Heart Association
|February 20, 2026
概括
对心房动中风的抗血栓策略演变为非维生素K抗剂口服抗凝剂单疗法,显示出更好的结果. 这一转变改善了在中风后的关键早期期间的患者护理.
科学领域:
- 心脏病学 心脏病学
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
背景情况:
- 研究了急性缺血性中风患者与心房动的抗血栓治疗的时间趋势.
- 研究了这些策略与临床结果之间的关联.
研究的目的:
- 描述与心房动相关的急性缺血性中风后抗血栓治疗策略的演变.
- 评估与这些不断变化的治疗模式相关的临床结果.
主要方法:
- 多中心前性队列研究,对2965名急性缺血性中风和心房的患者进行了研究.
- 随访数据收集的时间中位数为1.92年.
- 主要结局:复发性中风,心肌梗塞和全因死亡的组合;次要结局:单个组件和严重出血.
主要成果:
- 最初的抗血小板药物策略多样化,仅抗血小板药物治疗在48小时内最常见 (50.9%).
- 非维生素K抗剂口服抗凝剂单疗成为排泄 (65.7%) 的主导,并持续.
- 非维生素K抗剂口服抗凝剂单疗与抗血小板治疗或没有抗血小板治疗相比,主要终点的发病率较低.
结论:
- 对心房的中风患者的抗血栓治疗策略向非维生素K对抗剂口服抗凝剂单一疗法发展.
- 治疗选择对临床结果产生了重大影响,特别是在中风后的早期高风险时期.
相关概念视频
Venous Thrombosis III: Interprofessional Care
395
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
395
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
2.5K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.5K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
2.1K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.1K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
1.4K
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.4K
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
405
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
405
Venous Thrombosis IV: Nursing Management
285
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
285


